Mr. Fazeli brings with him over 25 years of experience conducting equity research as a pharmaceutical analyst.
— Sachs Associates (@SachsAssociates) February 17, 2023
Meet Sam at #Sachs_ELSF
More info @ https://t.co/hgPC4hxz57#Sachs_ELSF #SSLSW #lifesciences #partnering #bd #licensing @SamFazeli8 pic.twitter.com/ylC3Rtf1RL